Background Biliary atresia (BA) is a severe congenital disorder with progressive obstructive
cholangiopathy in young children. The inflammatory process has been recognized as one of …

Interleukin-33 (IL-33) plays a crucial role in inflammation. However, it is not clear whether IL-
33 levels are of clinical significance for patients with biliary atresia (BA). The purpose of this …

Primary biliary cirrhosis (PBC) is an autoimmune liver disease. Its histological
characteristics, such as progressive intrahepatic bile duct destruction, cholestasis, and liver …

Background/Aims: Biliary Atresia (BA) is a devastating pediatric liver disease and
characterized by aggressive liver fibrosis progression. The Interleukin-33 (IL-33)/ST2 …

The standard-of-care treatment for biliary atresia (BA) is surgical restoration of bile flow by
Kasai portoenterostomy. We aimed to study serum interleukin-(IL-) 12p40, a natural …

ABSTRACT Interleukin-31 (IL-31) has diverse biological functions. Increased IL-31 has been
found in some skin and autoimmune diseases. There has been no study reporting the …

Background & Aims Biliary atresia (BA) is a rare disease in infants, with unknown
mechanisms of pathogenesis. It is characterized by hepatobiliary inflammatory, progressive …

Objectives: The present study aimed to estimate the value of serum interleukin-33 (IL-33)
levels in infants with cholestasis, correlate serum IL-33 levels with the clinicopathological …

Results The mean value of IL-13Rα2 was significantly higher in delayed BA group
(11.05±10.9 ng/ml) compared to early BA (0.34±0.37 ng/ml), non-BA (0.54±0.85 ng/ml) and …

Injury to the biliary epithelium triggers inflammation and fibrosis, which can result in severe
liver diseases and may progress to malignancy. Development of a type 1 immune response …